Cargando…
S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL
BACKGROUND: Motivational deficits seem to be one of the main barriers in the recovery process among psychosis patients and have been shown to be very treatment resistant. Motives are conscious and unconscious affect-based needs that influence behavior toward specific incentives. Thus, they constitut...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234232/ http://dx.doi.org/10.1093/schbul/sbaa031.102 |
_version_ | 1783535717992890368 |
---|---|
author | Horisberger, Rahel Kaiser, Stefan Hartmann, Matthias |
author_facet | Horisberger, Rahel Kaiser, Stefan Hartmann, Matthias |
author_sort | Horisberger, Rahel |
collection | PubMed |
description | BACKGROUND: Motivational deficits seem to be one of the main barriers in the recovery process among psychosis patients and have been shown to be very treatment resistant. Motives are conscious and unconscious affect-based needs that influence behavior toward specific incentives. Thus, they constitute the basis of motivated behavior or the lack thereof. In this study, we investigated how individual differences in social motives relate to the phenomenology of motivational negative symptoms in patients with schizophrenia. METHODS: Fifty-nine patients with a diagnosis of schizophrenia were included into the sample. Negative symptoms were measured with the Brief Negative Symptom Scale and social motives with the Questionnaire for the Zurich Model of Social Motivation. Between-group differences, Pearson correlations and regression analysis were calculated. We replicated and extended the results in a second sample of forty-five psychosis patients, using the same methods. RESULTS: A comparison of healthy controls and schizophrenia patients revealed significant differences in social motives. Within the patient group, relationships between the characteristics of the individual motives, in particular the achievement motive, and the severity of the motivational negative symptoms, i.e. of asociality, avolition and anhedonia, could be described. In contrast, social motives cannot be associated with diminished expression, the non-motivational dimension of negative symptoms. The duration of the disease seems to be an additional influencing factor: When comparing the motivational dispositions of first episode patients with those of healthy people, no differences were found. However, a relationship between the duration of the disease and the characteristics of social motives can be described. DISCUSSION: Explicit social motives stand in a relationship with motivational negative symptoms. Since implicit and explicit motives may diverge, the aim of our future research is to additionally investigate the association with implicit motives. The inclusion of psychological factors helps to extend and improve psychotherapeutic interventions for psychosis patients. Since negative symptoms do not respond well to pharmacotherapy, further efforts in this direction are needed to understand the underlying mechanisms of this disease and to develop effective psychotherapy tools in the future. |
format | Online Article Text |
id | pubmed-7234232 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72342322020-05-23 S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL Horisberger, Rahel Kaiser, Stefan Hartmann, Matthias Schizophr Bull Poster Session I BACKGROUND: Motivational deficits seem to be one of the main barriers in the recovery process among psychosis patients and have been shown to be very treatment resistant. Motives are conscious and unconscious affect-based needs that influence behavior toward specific incentives. Thus, they constitute the basis of motivated behavior or the lack thereof. In this study, we investigated how individual differences in social motives relate to the phenomenology of motivational negative symptoms in patients with schizophrenia. METHODS: Fifty-nine patients with a diagnosis of schizophrenia were included into the sample. Negative symptoms were measured with the Brief Negative Symptom Scale and social motives with the Questionnaire for the Zurich Model of Social Motivation. Between-group differences, Pearson correlations and regression analysis were calculated. We replicated and extended the results in a second sample of forty-five psychosis patients, using the same methods. RESULTS: A comparison of healthy controls and schizophrenia patients revealed significant differences in social motives. Within the patient group, relationships between the characteristics of the individual motives, in particular the achievement motive, and the severity of the motivational negative symptoms, i.e. of asociality, avolition and anhedonia, could be described. In contrast, social motives cannot be associated with diminished expression, the non-motivational dimension of negative symptoms. The duration of the disease seems to be an additional influencing factor: When comparing the motivational dispositions of first episode patients with those of healthy people, no differences were found. However, a relationship between the duration of the disease and the characteristics of social motives can be described. DISCUSSION: Explicit social motives stand in a relationship with motivational negative symptoms. Since implicit and explicit motives may diverge, the aim of our future research is to additionally investigate the association with implicit motives. The inclusion of psychological factors helps to extend and improve psychotherapeutic interventions for psychosis patients. Since negative symptoms do not respond well to pharmacotherapy, further efforts in this direction are needed to understand the underlying mechanisms of this disease and to develop effective psychotherapy tools in the future. Oxford University Press 2020-05 2020-05-18 /pmc/articles/PMC7234232/ http://dx.doi.org/10.1093/schbul/sbaa031.102 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Poster Session I Horisberger, Rahel Kaiser, Stefan Hartmann, Matthias S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL |
title | S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL |
title_full | S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL |
title_fullStr | S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL |
title_full_unstemmed | S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL |
title_short | S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL |
title_sort | s36. treating negative symptoms of schizophrenia with a motive-specific intervention: a randomized brief intervention trial |
topic | Poster Session I |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234232/ http://dx.doi.org/10.1093/schbul/sbaa031.102 |
work_keys_str_mv | AT horisbergerrahel s36treatingnegativesymptomsofschizophreniawithamotivespecificinterventionarandomizedbriefinterventiontrial AT kaiserstefan s36treatingnegativesymptomsofschizophreniawithamotivespecificinterventionarandomizedbriefinterventiontrial AT hartmannmatthias s36treatingnegativesymptomsofschizophreniawithamotivespecificinterventionarandomizedbriefinterventiontrial |